The company held the 7th meeting of the 11th board of directors and the 7th meeting of the 10th board of supervisors to review and approve the annual work report and other related proposals
Release time:
2022-05-05
News from our newspaper # February 16 , Chairman Jiang Xiaomeng of the Group Company presided over the meeting of the 11th Board of Directors of the Company, it reviewed and approved 17 related reports and proposals such as 2021 annual board of directors report, 2021 annual general manager business report, 2021 annual report, 2021 annual financial final accounts report, 2021 annual profit distribution plan, etc.
General Manager's report pointed out that 2021 is the first year of the national "14th Five-Year Plan" , The management team, according to the company's five-year development plan and the annual management plan approved by the board of directors, focuses on the general working policy of "following the rules, keeping the right and bringing forth new ideas, reforming and innovating, and continuously improving, calmly deal with the new coronary pneumonia epidemic, raw material prices ups and downs, production restrictions and power restrictions and many other challenges, better to complete the work objectives set at the beginning of the year. As of the end of 2021 , the company's total assets were 70.24 .9 billion yuan, up 10.74% year-on-year, and the net assets attributable to shareholders of listed companies were 52.07 .3 billion yuan, up 17.39% year-on-year. For the whole year, operating income reached 38.05 .7 billion yuan, up 17.17% year-on-year, net profit attributable to shareholders reached 9.24 .1 billion yuan, up 58.12% year-on-year, and operating performance reached the best level in history.
2021, the company's cement plate industry chain extension war made new progress, holding the establishment of Hubei peak new building materials Co., Ltd., orderly promote the mechanism of sand project. Actively participated in the major asset restructuring of Tianshan shares and achieved good investment returns. All cement enterprises under the company continue to implement benchmarking management and fine management, carry out in-depth "three reductions and three improvements" activities, steadily implement various technological transformation work, strictly control production costs, and continuously improve the operation efficiency of enterprises. A total of cement clinker ,675 tons were sold throughout the year, up 28% year on year. Daye Peak manages the procurement of raw materials through multi-channel, open and transparent, and full supervision, and strictly controls the procurement cost while ensuring the quality. Continuously optimize the batching scheme, complete the technical transformation of the automatic batching system, increase the proportion of limestone in raw materials, and reduce the cost of raw materials; Continuously optimize the process parameters and use the MES system to trace the optimal parameters, combined with the implementation of more than ten technical transformations such as low-nitrogen combustion at the kiln end and dust collection system at the kiln end, the stability of the equipment has been improved, the overall production capacity of the kiln system has been improved, and the annual cement output has reached the best level in history. Yunnan Jianfeng strictly controls the procurement cost of raw materials by strengthening bidding management. Through the technical renovation of grate cooler, preheater and other equipment, the output of rotary kiln has been effectively increased. Affected by the completion of some key projects in the region and the commissioning of new cement production capacity, the competition in the cement market in this region has intensified and the price has dropped greatly. Therefore, the company further strengthened the regional market segmentation work according to market changes in time and formulated differentiated marketing strategies for different market segments, basically maintain the balance of production and sales. 2021 is the first complete year after Guizhou Jianfeng was put into production. Guizhou Jianfeng relies on the advanced second-generation new dry-process cement production line and adopts digital intelligent control technology to realize all-round intelligent management such as safe production, product quality, material consumption and energy consumption. Strengthen operator training, improve skill level, timely adjust and optimize process parameters, and ensure product quality stability; The whole line has reached the standard and reached the production capacity, coal consumption, electricity consumption, operation rate, kiln production, labor productivity and other indicators reached a good level.
2021, the company made progress in a number of technological innovations and engineering constructions in the pharmaceutical sector. The construction of the annual production of 20 .9 billion solid preparations (internationalization) project in Jinxi Production Base of Jianfeng Pharmaceutical Co., Ltd. is progressing in an orderly manner. At present, the civil engineering and equipment installation and commissioning of the project have been basically completed, and the preliminary preparations for project acceptance and application for certification of cGMP are underway; new North Card and Peak North Card continue to implement comprehensive technological transformation, and intend to upgrade on the basis of existing pesticides and pharmaceutical intermediates, build a comprehensive research and development and production base for APIs, pharmaceutical intermediates and pesticides, and actively promote the industrial upgrading strategy of the integration of APIs and preparations in the pharmaceutical sector of the company. Jianfeng Pharmaceutical and its subsidiaries further increased their investment in research and development and completed the registration of moxifloxacin hydrochloride eye drops, lenvatinib mesylate capsules, valsartan amlodipine tablets and esomeprazole magnesium enteric-coated dry suspension 4 drugs. Peak pharmaceutical products won the bid for the first time in the national drug centralized procurement, olopatadine hydrochloride eye drops won the bid for the fourth batch of national drug centralized procurement, which is conducive to the market promotion of the product, sales have been greatly improved.
In addition, Jianfeng Health has completed the research and development of health food such as coenzyme Q10 soft capsule and broken ganoderma lucidum spore powder, and has obtained the record. Completed the development of many functional foods such as vitality V5 liquid drink and collagen liquid drink, and has now listed 6 ; "Development and Industrialization of Wall-broken Ganoderma lucidum Spore Powder for Enhancing Immunity" was approved by Jinhua Municipal Technology Innovation Project in 2021 . "Cranberry Extract" won the project of key high-tech products in Zhejiang Province in 2021 . Peak cable carried out the subway communication cable "Zhejiang manufacturing" standard construction work, high-speed data transmission with twisted pair communication cable through the "Zhejiang manufacturing" certification, won the representative of Zhejiang manufacturing benchmark "word mark". According to the development trend of regional trade and logistics, combined with the characteristics of the enterprise itself, Jianfeng International Trade has continuously improved its business development model and promoted the development of modern warehousing logistics, commodity supply chain and network freight platform business in an orderly manner. On the day of
, the company also held the st meeting of the 10th board of supervisors, deliberating and passing related reports and proposals such as the company's 2021 annual board of supervisors report. (remaining fruit)
More information
Jingmai Airport Test Flight Successfully Runway Cement Spike Manufacturing
On April 7, a Boeing 737-700 aircraft of China Eastern Airlines Yunnan took off from Kunming. After completing two flight test subjects, it landed safely at Lancang Jingmai Airport. This not only marked the basic completion of the airport flight area, The official start of the test flight also marked that the "Peak" brand airport runway cement passed the first "final exam". Lancang Jingmai Airport is a major project with milestone significance in the history of Pu'er transportation construction. Since then, an air corridor connecting southwest Yunnan and Southeast Asia has been added between Kunming and Pu'er, which will greatly promote the development and utilization of tourism resources in Lancang, Menglian and Ximeng "Pu'er Green Triangle" area, and promote the sustainable development of local economy and society; it is of great significance to strengthen the city's national defense construction, maintain border stability, promote national unity, improve emergency rescue capabilities, and promote Pu'er's integration into the country's "Belt and Road" construction. Since the start of the construction of the airport, Yunnan Jianfeng has been paying close attention to it, organizing technical research and repeated tests, and finally produced high-quality airport runway special cement, and with excellent product quality, superior product performance and high-quality service, it has become a runway for Lancang Airport. Cement manufacturer. This not only fills the gap of "peak" airport special cement, but also is of great significance to promote the "peak" brand and improve the market influence of enterprises. It is understood that Jingmai Airport is initially confirmed to be officially opened to traffic at the end of May. (Li Liangping)
2020
07-31
Jianfeng Pharmaceutical Artificial Niuhuang Project Starts
News from this newspaper Jianfeng Pharmaceutical artificial bezoar technical transformation project recently started construction in Qiubin Factory. Artificial bezoar has the effect of clearing away heat and detoxification, resolving phlegm, and is commonly used in Chinese and Western medicines such as colds, clearing away heat and detoxification. As the vast majority of artificial bezoar-related preparations are national essential drugs, with the further implementation of the medical reform policy, the downstream industry of artificial bezoar will enter a new round of business cycle. Jianfeng Pharmaceutical has many years of experience in artificial bezoar production. The technological transformation project will use the existing workshop structure, public works and operators of Qiubin Factory to achieve an annual production capacity of 100 tons of artificial bezoar by adding production equipment such as double cone rotary vacuum drying, horizontal ball mill pulverizer unit, hopper and hoist, closed screening system, and upgrading some public systems. According to the project implementation plan, the project will complete the civil engineering in May. Complete the commissioning, testing and verification of equipment and facilities in July, with trial production conditions; Strive to complete the on-site inspection of GMP certification before the end of December. At present, the factory buildings in Qiubin are vacated and the site is cleaned up. It is understood that the production of natural bezoar is very small, the price is extremely high, and the market rarely provides it. As a biochemical API, artificial bezoar has fewer manufacturers. In the past, due to relatively loose supervision, the testing methods of raw materials and finished products are relatively simple, the quality control indicators are not perfect, and the quality of products on the market is uneven. It is imperative to improve the quality standards. To this end, the State Food and Drug Administration issued the "Biochemical Drug GMP Quality Management Practice (Draft for Comment)" at the end of 2016, which was implemented in March 2017. spike medicine
2020
07-31
Recently, Jianfeng Health has been awarded a number of plaques and certificates by the Department of Science and Technology of Zhejiang Province, the people's Government of Jinhua City, and the Science and Technology Bureau of Jinhua City. They are "Zhejiang Science and Technology small and medium-sized Enterprises", "Jinhua High-tech Enterprises", "Jinhua Agricultural Science and Technology Enterprises", "Jinhua Agricultural Science and Technology Research and Development Center" and so on. According to the relevant requirements, Zhejiang science and technology-based small and medium-sized enterprises must be small and medium-sized enterprises with independent intellectual property rights, proprietary technology or advanced knowledge, engaged in the research, development, production, sales and service of high-tech and its products, and the proportion of enterprises engaged in scientific and technological research and development personnel accounting for no less than 10% of the total number of employees in that year. Since its establishment, Jianfeng Health has attached great importance to the training of scientific and technological personnel, paid attention to the application of its own intellectual property rights, paid attention to product research and development and the protection of intellectual property rights, promoted the application of intellectual property rights, and encouraged employees to invent and create. By the end of 2016, a total of 8 invention patents and 5 appearance patents had been applied, and 1 invention patent and 5 appearance patents had been obtained. High-tech enterprises in Jinhua City must meet the requirements of the ''High-tech Fields Supported by the State, ''and continue to carry out research and development and technological achievements transformation. Their main products (services) have independent intellectual property rights (authorized, registered or accepted). There are certain requirements for the proportion of R & D personnel, the proportion of R & D funds and the income of high-tech products. The acquisition of high-tech enterprises in Jinhua City has laid the foundation for the further declaration of national high-tech enterprises in the future. In the identification of agricultural science and technology enterprises in Jinhua City, the field of peak health technology belongs to the deep processing technology and equipment of agricultural products, Chinese herbal pieces and plant extracts.
2020
07-31
Jingmai Airport Test Flight Successfully Runway Cement Spike Manufacturing
On April 7, a Boeing 737-700 aircraft of China Eastern Airlines Yunnan took off from Kunming. After completing two flight test subjects, it landed safely at Lancang Jingmai Airport. This not only marked the basic completion of the airport flight area, The official start of the test flight also marked that the "Peak" brand airport runway cement passed the first "final exam". Lancang Jingmai Airport is a major project with milestone significance in the history of Pu'er transportation construction. Since then, an air corridor connecting southwest Yunnan and Southeast Asia has been added between Kunming and Pu'er, which will greatly promote the development and utilization of tourism resources in Lancang, Menglian and Ximeng "Pu'er Green Triangle" area, and promote the sustainable development of local economy and society; it is of great significance to strengthen the city's national defense construction, maintain border stability, promote national unity, improve emergency rescue capabilities, and promote Pu'er's integration into the country's "Belt and Road" construction. Since the start of the construction of the airport, Yunnan Jianfeng has been paying close attention to it, organizing technical research and repeated tests, and finally produced high-quality airport runway special cement, and with excellent product quality, superior product performance and high-quality service, it has become a runway for Lancang Airport. Cement manufacturer. This not only fills the gap of "peak" airport special cement, but also is of great significance to promote the "peak" brand and improve the market influence of enterprises. It is understood that Jingmai Airport is initially confirmed to be officially opened to traffic at the end of May. (Li Liangping)
2020
07-30
Peak Pharmaceutical was rated as a national intellectual property advantage enterprises
The score ranked first among Jinhua participating enterprises. A few days ago, Peak Pharmaceutical Company was rated as a national intellectual property advantage enterprise. The selection of national intellectual property advantage enterprises is organized by the State Intellectual Property Office. The purpose is to accelerate the formation of a group of Chinese intellectual property leading enterprises with independent intellectual property rights, well-known brands and international competitive advantages, and achieve the development goal of strong intellectual property enterprises. Since Jianfeng Pharmaceutical introduced the GB-T29490-2013 "Enterprise Intellectual Property Management Standard" in 2013, it has been rated as a patent demonstration enterprise in Zhejiang Province in 2013. In 2014, the "Jianfeng" trademark obtained a famous trademark in Zhejiang Province, and the first edition of the "Intellectual Property Manual" was compiled and implemented in 2015. In 2016, it passed the third-party certification of the GB-T29490-2013 "Enterprise Intellectual Property Management Standard". The "Jianfeng" trademark was rated as a well-known trademark by the State Administration of China. In the application and selection of national knowledge by superior enterprises, 52 enterprises in Zhejiang Province won this honor, ranking second in the country in number; Jianfeng Pharmaceutical ranked first among Jinhua participating enterprises. (Zhang Mingyin)
2020
07-31
Group Party Committee to determine the annual work plan
The party Committee of the group company has determined its work ideas and work plan for 2017 a few days ago, and relevant work has been arranged below. In view of the current new political and economic situation and the task of enterprise transformation and development, the general requirements of the Party Committee of the Group Company for 2017 are: to thoroughly study and implement the spirit of the Sixth Plenary Session of the 18th CPC Central Committee and the series of important speeches by General Secretary Xi Jinping, the spirit of the Seventh Party Congress of Jinhua City, to closely revolve around the center of enterprise production, operation and reform and development, and to adhere to scientific development and cross-regional development as the first priority, in order to continue to carry out the study and education of "five stars striving for innovation" and "two learning and one doing", we should highlight the main line of comprehensively and strictly administering the party according to the rules, firmly establish the political consciousness, overall situation consciousness, core consciousness and alignment consciousness of the majority of Party members and cadres, strengthen and improve the party building work in enterprises in the spirit of reform, and strive to improve the scientific, standardized and institutionalized level of Party building work in enterprises, in order to promote the scientific development of the group company, leapfrog development and harmonious development, it provides a strong political, ideological and organizational guarantee. The working idea of the Party Committee of the Group Company in 2017 is to focus on "one center", adhere to "one concept", highlight "three key points" and do a good job in "three constructions". That is: centering on the "one center" of enterprise production, operation and reform and development, we should strive to strengthen the "one concept" of "the organic unity of the party's leadership and the improvement of corporate governance"; to "thoroughly implement the main responsibility of the party committee; continue to carry out the study and education of" two learning and one doing "; and improve the system of party building work" as the "three key points", and focus on "team building and team building
2020
07-31